News

We are delighted to announce that TBVI will once again organize its annual meeting in the Swiss mountains of Les Diablerets from 30-31 January 2024. TB vaccine researchers, developers, funders [...]

The TuBerculosis Vaccine Initiative (TBVI) Governance Board would like to announce a vacancy for the Executive Director of the organization. The Board has launched the search for a new Director [...]

TBVI Governance Board Communiqué Tuberculosis (TB) is a major unsolved global health problem. Novel vaccines against TB will be critical tools to ultimately end this silent pandemic. TBVI and its [...]

From 15-18 May 2023, the first annual progress meeting of the MTBVAC phase III clinical trial EDCTP co-funded project took place in Andasibe and Antananarivo, Madagascar. The consortium, composed [...]

The Horizon Europe programme has funded the ITHEMYC project to establish a critical path for selection of promising innovative adjunct TB immunotherapies and progress 2 of these immunotherapies [...]